Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines-Reference-Cited by-同舟云学术

Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines

Published:2020-08 Issue:8 Volume:13 Page:100444
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Larenas-Linnemann Désirée^ORCID,Rodríguez-Pérez Noel^ORCID,Luna-Pech Jorge A.^ORCID,Rodríguez-González Mónica^ORCID,Blandón-Vijil María Virginia^ORCID,Del-Río-Navarro Blanca E.^ORCID,Costa-Domínguez María del Carmen^ORCID,Navarrete-Rodríguez Elsy Maureen^ORCID,Macouzet-Sánchez Carlos^ORCID,Ortega-Martell José Antonio^ORCID,Pozo-Beltrán César Fireth^ORCID,Estrada-Cardona Alan^ORCID,Arias-Cruz Alfredo^ORCID,Rodríguez Galván Karen Guadalupe,Brito-Díaz Herson^ORCID,Canseco-Raymundo María del Rosario^ORCID,Castelán-Chávez Enrique Emanuel^ORCID,Escalante-Domínguez Alberto José^ORCID,Gálvez-Romero José Luis^ORCID,Gómez-Vera Javier^ORCID,González-Díaz Sandra Nora^ORCID,Guerrero-Núñez María Gracia Belinda^ORCID,Hernández-Colín Dante Daniel^ORCID,Macías-Weinmann Alejandra^ORCID,Mendoza-Hernández David Alejandro^ORCID,Meneses-Sánchez Néstor Alejandro^ORCID,Mogica-Martínez María Dolores^ORCID,Moncayo-Coello Carol Vivian^ORCID,Montiel-Herrera Juan Manuel^ORCID,O'Farril-Romanillos Patricia María^ORCID,Onuma-Takane Ernesto^ORCID,Ortega-Cisneros Margarita^ORCID,Rangel-Garza Lorena^ORCID,Stone-Aguilar Héctor^ORCID,Torres-Lozano Carlos^ORCID,Venegas-Montoya Edna^ORCID,Wakida-Kusunoki Guillermo^ORCID,Partida-Gaytán Armando^ORCID,López-García Aída Inés^ORCID,Macías-Robles Ana Paola^ORCID,Ambriz-Moreno María de Jesús^ORCID,Azamar-Jácome Amyra Ali^ORCID,Beltrán-De Paz Claudia Yusdivia^ORCID,Caballero-López Chrystopherson^ORCID,Fernández de Córdova-Aguirre Juan Carlos^ORCID,Fernández-Soto José Roberto^ORCID,Lozano-Sáenz José Santos^ORCID,Oyoqui-Flores José Joel^ORCID,Osorio-Escamilla Roberto Efrain^ORCID,Ramírez-Jiménez Fernando^ORCID,Rivero-Yeverino Daniela^ORCID,Martínez Infante Eric^ORCID,Medina-Ávalos Miguel Alejandro^ORCID

Funder

Diemsa

Inmunotek México

Alerquim

Mylan Mexico

Abalat

Senosiain

Pisa

Glenmark

Allakos

Amstrong

Astrazeneca

Boehringer Ingelheim

Chiesi

DBV Technologies

Grunenthal

GSK

MEDA

Menarini

MSD

Novartis

Pfizer

Sanofi

Siegfried

UCB

Gossamer

TEVA

Purina institute

AstraZeneca

Grünenthal

Sandoz

Nestlé Nutrition Institute

GlaxoSmithKline

Instituto Nacional de Pediatria

Healthy Kids Polanco S.C.

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference64 articles.

1. [Consenso nacional de inmunoterapia] sp;Pedroza;Rev Alerg Mex,1998

2. [Mexican clinical practice guidelines of immunotherapy 2011];Larenas-Linnemann;Rev Alerg Mex,2011

3. Development of the AGREE II, part 2: assessment of validity of items and tools to support application;Brouwers;CMAJ (Can Med Assoc J),2010

4. National clinical practice guidelines for allergen immunotherapy: an international assessment applying AGREE-II;Larenas-Linnemann;Allergy,2018

5. The ADAPTE Manual and Resource Toolkit for Guideline Adaptation. Version 2.0,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?;Expert Review of Respiratory Medicine;2023-08-03

2. Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023;World Allergy Organization Journal;2023-05

3. House dust mite liquid SLIT effective in atopic dermatitis even with suboptimal dosing;The Journal of Allergy and Clinical Immunology: In Practice;2022-07

4. Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets;Current Therapeutic Research;2022

5. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience;The Journal of Allergy and Clinical Immunology: In Practice;2021-05